Medicare Enrolled
Dr. Sabry Omar, MD
Cardiovascular Disease · Venice, FL
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Omar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Omar? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Omar
Dr. Sabry Omar is a cardiovascular disease in Venice, FL, with 13 years in practice. Based on federal Medicare data, Dr. Omar performed 5,170 Medicare services across 3,463 unique beneficiaries.
Between the years covered by Open Payments, Dr. Omar received a total of $11,548 from 41 pharmaceutical and/or device companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Omar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice▲ Top 20% volume in FL$ $11,548 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,170
Medicare services
Top 20% in FL for cardiovascular disease
3,463
Unique beneficiaries
$145
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~398 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) | 930 | $136 | $367 |
| Regadenoson injection (Lexiscan) for heart stress test | 745 | $42 | $130 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 542 | $350 | $797 |
| Ultrasound of both sides of head and neck blood flow | 330 | $141 | $469 |
| Echocardiogram, transthoracic | 326 | $144 | $397 |
| Hospital follow-up visit, high complexity | 308 | $94 | $200 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 271 | $328 | $722 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 269 | $47 | $216 |
| Injection of drug or substance into vein | 240 | $28 | $105 |
| Electrocardiogram (EKG), 12-lead | 137 | $11 | $42 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 134 | $10 | $25 |
| Initial hospital admission, high complexity | 133 | $134 | $389 |
| Office visit, established patient (30-39 min) | 118 | $90 | $264 |
| New patient office visit, complex (60-74 min) | 113 | $169 | $448 |
| Cardiac catheterization | 98 | $189 | $692 |
| Ultrasound study of arm and leg arteries | 55 | $55 | $236 |
| Coronary stent placement | 52 | $446 | $1,279 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 50 | $28 | $60 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 48 | $21 | $148 |
| Ultrasound of leg arteries or artery grafts | 44 | $172 | $449 |
| Ultrasound of heart, follow-up | 31 | $19 | $240 |
| Programming of dual lead pacemaker system | 27 | $60 | $126 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $83 | $502 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $14 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $2 | $6 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 22 | $130 | $394 |
| Insertion of heart rhythm monitor under skin | 17 | $3,265 | $9,779 |
| Shockwave destruction of calcified plaque in coronary artery accessed through skin using catheter | 16 | $123 | $1,500 |
| Ultrasonic guidance for blood vessel access | 13 | $12 | $28 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $47 | $191 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $104 | $553 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 11 | $144 | $368 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.3% high complexity
39.1% medium
49.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,548
Total received (2018-2024)
Avg $1,650/year across 7 years
Top 22% in FL for cardiovascular disease
41
Companies
305
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,548 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,824
2023$2,187
2022$1,382
2021$305
2020$570
2019$3,928
2018$1,351
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$1,967
Edwards Lifesciences Corporation
$1,456
Boston Scientific Corporation
$1,443
Abbott Laboratories
$996
Amgen Inc.
$492
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$454
ShockWave Medical, Inc
$407
Novartis Pharmaceuticals Corporation
$356
Becton, Dickinson and Company
$331
PFIZER INC.
$318
Penumbra, Inc.
$314
BOSTON SCIENTIFIC CORPORATION
$309
ABIOMED
$288
Inari Medical, Inc.
$218
BIOTRONIK INC.
$198
AstraZeneca Pharmaceuticals LP
$166
Merck Sharp & Dohme LLC
$163
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
Silk Road Medical, Inc.
$155
Janssen Pharmaceuticals, Inc
$152
Astellas Pharma US Inc
$146
Kestra Medical Technology Services, Inc.
$140
Cardiovascular Systems Inc.
$137
Medtronic, Inc.
$125
Cardinal Health 200, LLC
$85
E.R. Squibb & Sons, L.L.C.
$70
Kiniksa Pharmaceuticals International, plc
$64
Bard Peripheral Vascular, Inc.
$62
HEARTFLOW, INC.
$59
CARDIVA MEDICAL, INC.
$59
Philips Electronics North America Corporation
$50
Alnylam Pharmaceuticals Inc.
$35
Philips North America LLC
$28
SCPHARMACEUTICALS INC.
$27
Biosense Webster, Inc.
$24
Chiesi USA, Inc.
$20
Baxter Healthcare
$20
Actelion Pharmaceuticals US, Inc.
$18
Lantheus Medical Imaging, Inc.
$15
G Medical Diagnostic Services, Inc.
$12
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 42.1% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (6586) Pioneer · 3F · ACUTHERM Catheter · Allure Quadra RF CRT Pacemaker · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BIOMONITOR · BRILINTA · BodyGuardian · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARTO 3 · CROSSBOSS · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Cougar · Definity · Diamondback Coronary · Diamondback Peripheral · DxTerity · ELIQUIS · ELUVIA · EMBLEM · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · Fortify Assura · GENERAL ATHERECTOMY · GENERAL VASCULAR ACCESS · General - Structural Heart · Hillrom - ABPM 7100 Ambulatory Blood Pressure Monitor · ICDs · IGT D FM · Impella · Indigo System · JARDIANCE · KENGREAL · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LINQ II · LUTONIX Drug Coated Balloon · LifeVest · MITRACLIP · Mitra Clip system · MitraClip System · ONPATTRO · OPTOWIRE · Optis Coronary Imaging System · PAMIRA · PRADAXA · Pacemakers · Perclose ProGlide suture mediated closure system · Quadra Assura CRT Defibrillator · Quartet CRT Lead · ROTABLATOR · Renamic Neo · Repatha · Resolute · Reveal LINQ · RotarexS 6 F x 135 cm · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · StarClose SE vascular closure system · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · Varithena Administration Pack · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WOLVERINE · XARELTO · XIENCE SIERRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $223 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
72
Per 100K population
16.0
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Omar is a cardiac imaging specialist, with above-average Medicare volume (top 20% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Omar experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Omar performed 930 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Omar receive payments from pharmaceutical companies?
Yes. Dr. Omar received a total of $11,548 from 41 companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Omar's costs compare to other cardiovascular diseases in Venice?
Dr. Omar's average Medicare payment per service is $145. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Omar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Venice
Browse cardiovascular diseases in Venice ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology